STIM

Neuronetics, Inc. operates in the Healthcare sector within the Medical Devices industry. The company has a market capitalization of $96.57 million and generates revenue of $129.87 million (TTM). With 716 employees, Neuronetics is a relatively small player in its field. Financially, Neuronetics faces challenges with negative net income of -$44.5 million (TTM) and EBITDA of -$34.2 million. The company's gross margin stands at 50.9%, while operating and profit margins are -19.6% and -34.3%, respectively. Returns on equity and assets are also unfavorable, with ROE at -219.0% and ROA at -21.2%. Neuronetics has a significant amount of debt, totaling $90.75 million, but maintains a current ratio of 2.24. Neuronetics' valuation is characterized by a forward P/E ratio of -2.97, which suggests that investors are currently pricing the company's future earnings highly negatively. The price to sales ratio stands at 0.74, and the EV/EBITDA multiple is -4.83. Revenue growth has been significant, increasing by 101.3% year-over-year (TTM).